Tue, Jul 22, 2014, 9:06 AM EDT - U.S. Markets open in 24 mins.

Recent

% | $
Click the to save as a favorite.

Momenta Pharmaceuticals Inc. Message Board

  • islb3 islb3 Aug 2, 2013 2:52 PM Flag

    Hopeless until 2014

    Still holding a nice slug of cash, but that's evaporating quickly. Revenues all but disappeared and only nearer term hope is a launch in 2014 which is iffy and who's to say if they get to market they'll have any success with sales. Nice short opportunity for the remainder of the year as reality settles in.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You might be right, but then again we can't discount the implication of an FDA approval for MNTA;s ANDA of copaxane which, good or bad, should certainly come before the year ends. This will move the stock upward imo.
      While it might be true that there is no givens regarding sales in 2014, Id hardly bet against Navartus/Sandoz if the FDA does give them approval.
      Furthmore I don't believe that Teva's effort to preserve their revenue stream by creating a 3x a week dose vs a daily dose will be able to materialize the preservation of their revenue they way they intend it to. net net.. upside from here even if we see a little pullback still.

    • What?

 
MNTA
10.99Jul 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.